Prediction of survival in patients with cardiogenic shock and multiorgan failure treated with biventricular assist device

ASAIO Journal

Volumn 56, Issue 4, 2010, Pages 273-278

  Potapov, Evgenij V ^a   Stepanenko, Alexander ^a   Kukucka, Marian ^a   Ba Fadhl, Faiz H ^a   Qedra, Naser ^a   Weng, Yuguo ^a   Pasic, Miralem ^a   Lehmkuhl, Hans B ^a   Krabatsch, Thomas ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYOCARDIAL INFARCTION; ASSIST DEVICE; BODY TEMPERATURE; CARDIOGENIC SHOCKS; CLINICAL OUTCOME; HEART TRANSPLANTATION; MECHANICAL CIRCULATORY SUPPORT; MULTI VARIATE ANALYSIS; MULTIORGAN FAILURE; ORGAN FAILURE; PATHOPHYSIOLOGICAL; RETHORACOTOMY; SYSTOLIC BLOOD PRESSURE; VENTRICULAR ASSIST DEVICE;

BLOOD; BLOOD PRESSURE; DECISION MAKING; FIBER OPTIC SENSORS; FORECASTING; MERCURY (METAL); MULTIVARIANT ANALYSIS; POPULATION STATISTICS; TRANSPLANTATION (SURGICAL);

QUALITY ASSURANCE;

BIOLOGICAL MARKER;

ACIDOSIS; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOGENIC SHOCK; CHILD; FEMALE; HEART ASSIST DEVICE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PH; RISK FACTOR; TREATMENT OUTCOME;

ACIDOSIS; ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHILD; FEMALE; HEART-ASSIST DEVICES; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RISK FACTORS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954957393     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181dbefd0     Document Type: Article

References (27)

1. El-Banayosy A, Arusoglu L, Kizner L, et al: Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: A single-center retrospective study on more than 100 patients. J Heart Lung Transplant 19: 964-968, 2000.
2. Farrar DJ: Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 13: 93-100, 1994.
3. Farrar DJ: The thoratec ventricular assist device: A paracorporeal pump for treating acute and chronic heart failure. Semin Thorac Cardiovasc Surg 12: 243-250, 2000.
4. Kirsch M, Vermes E, Radu C, et al: Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec ventricular assist device. Eur J Cardiothorac Surg 34: 262-267, 2008.
5. Reinhartz O, Farrar DJ, Hershon JH, et al: Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 116: 633-640, 1998.
6. Lahpor J, Khaghani A, Hetzer R, et al: European results with a continuous-flow ventricular assist device for advanced heartfailure patients. Eur J Cardiothorac Surg 37: 357-361, 2009.
7. Potapov EV, Jurmann MJ, Drews T, et al: Patients supported for over 4 years with left ventricular assist devices. Eur J Heart Fail 8: 756-759, 2006.
8. Potapov EV, Loforte A, Weng Y, et al: Experience with over 1000 implanted ventricular assist devices. J Card Surg 23: 185-194, 2008.
9. Drews T, Loebe M, Hennig E, et al: The 'Berlin Heart' assist device. Perfusion 15: 387-396, 2000.
10. Horovitz JH, Carrico CJ, Shires GT: Pulmonary response to major injury. Arch Surg 108: 349-355, 1974.
11. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996.
12. Marshall JC, Cook DJ, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638-1652, 1995.
13. Kormos RL, Gasior TA, Kawai A, et al: Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 111: 773-782, 1996.
14. Potapov EV, Hennig F, Wagner FD, et al: Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg 27: 899-905, 2005.
15. Friedel N, Viazis P, Schiessler A, et al: Recovery of end-organ failure during mechanical circulatory support. Eur J Cardiothorac Surg 6: 519-522, 1992.
16. Schiessler A, Friedel N, Weng Y, et al: Mechanical circulatory support and heart transplantation. Pre-operative status and outcome. ASAIO J 40: 476-481, 1994.
17. Potapov EV, Wagner FD, Hennig FK, et al: Natriuretic peptides as predictors of clinical course in patients with end-stage heart failure. J Heart Lung Transplant 22: S206, 2003.
18. Potapov EV, Weng Y, Hausmann H, et al: New approach in treatment of acute cardiogenic shock requiring mechanical circulatory support. Ann Thorac Surg 76: 2112-2114, 2003.
19. Combes A, Leprince P, Luyt CE, et al: Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36: 1404-1411, 2008.
20. Idelchik GM, Simpson L, Civitello AB, et al: Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant 27: 106-111, 2008.
21. De Robertis F, Rogers P, Amrani M, et al: Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 27: 474-478, 2008.
22. John R, Liao K, Lietz K, et al: Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 134: 351-358, 2007.
23. Shuhaiber JH, Jenkins D, Berman M, et al: The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant 27: 158-164, 2008.
24. Hoefer D, Ruttmann E, Poelzl G, et al: Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg 82: 28-33, 2006.
25. Jurmann MJ, Siniawski H, Erb M, et al: Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77: 1642-1647, 2004.
26. Rossiter-Thornton M, Arun V, Forrest AP, et al: Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery. Heart Lung Circ 17: 243-245, 2008.
27. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW: A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 152: 469.e1-469.e8, 2006.